Prucalopride Tablet
Product Images NDC 27241-294

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Prucalopride (NDC 27241-294). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ajanta Pharma Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Prucalopride Structure)

FDA Label Image

1mg (Prucalopride Tablets 1 mg 30s Label 3037038)

This text provides information about a medication called Prucalopride in tablet form. Each film-coated tablet contains 1 mg of Prucalopride (equivalent to 1.32 mg of Prucalopride succinate). The storage conditions are specified to be between 20°C to 25°C (68°F to 77°F), with permissible excursions between 15°C and 30°C (69°F and 86°F). The package is child-resistant, and it is recommended to store the tablets in the original container to protect them from moisture. The usual dose is one tablet once daily. The tablets are supplied in a pack containing 30 tablets. The product is marketed by Ajanta Pharma USA Inc. with manufacturing in India.*

FDA Label Image

2mg (Prucalopride Tablets 2 mg 30s Label 3037039)

This is information about Prucalopride tablets containing 2 mg of Prucalopride succinate each. The tablets should be stored at a temperature between 20°C to 25°C, with excursions allowed between 16°C and 30°C. The package is child-resistant and should be stored in the original container to protect from moisture. The usual dose is one tablet daily. These tablets are marketed by Ajanta Pharma USA Inc. and are made in India.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.